Gastrointestinal Stromal Tumor clinical trials

Explore recruiting gastrointestinal stromal tumor clinical trials.

Recruiting gastrointestinal stromal tumor studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastrointestinal Stromal Tumor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of adjuvant Imatinib in patients with intermediate-risk gastrointestinal stromal tumor with a high-risk Genomic Grade Index. Multicenter, prospective, randomized study.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

ATEZOGIST – A prospective, randomized, multicenter, comparative study of the efficacy of imatinib resumption combined with atezolizumab versus imatinib resumption alone in patients with unresectable advanced gastrointestinal stromal tumors (GIST) after failure of standard treatments

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Three versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk for recurrence: A randomised phase III study.

Sweden, Finland, Norway, Germany, Austria, Netherlands +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to learn the effects of ripretinib (study drug) on how midazolam behaves in the body of people with advanced gastrointestinal stromal tumor

Netherlands, Spain, Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

(Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors

Germany, Spain, Sweden, Denmark, Hungary, France +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Master Protocol for the Multi-Cohort, Phase 1/2 Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Portugal, Netherlands, Denmark, Spain, Italy, Germany +2 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Gastrointestinal Stromal Tumor trials by city

Gastrointestinal Stromal Tumor in Toronto Gastrointestinal Stromal Tumor in Vancouver Gastrointestinal Stromal Tumor in Montreal Gastrointestinal Stromal Tumor in Calgary Gastrointestinal Stromal Tumor in Edmonton Gastrointestinal Stromal Tumor in Ottawa Gastrointestinal Stromal Tumor in Winnipeg Gastrointestinal Stromal Tumor in Quebec City Gastrointestinal Stromal Tumor in Hamilton Gastrointestinal Stromal Tumor in Kitchener Gastrointestinal Stromal Tumor in London Gastrointestinal Stromal Tumor in Halifax Gastrointestinal Stromal Tumor in New York Gastrointestinal Stromal Tumor in Los Angeles Gastrointestinal Stromal Tumor in Chicago Gastrointestinal Stromal Tumor in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease